XNYS
USNA
Market cap270mUSD
Oct 08, Last price
14.66USD
1D
-0.07%
1Q
-33.30%
Jan 2017
-76.05%
Name
USANA Health Sciences Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Related entities
Subsidiaries
USANA HEALTH SCIENCES INDIA PRIVATE LIMITED
Key people
Jim H. Brown
President · since 2019
Kevin G. Guest
Chairman of the Board, Chief Executive Officer · since 2020
G Douglas Hekking
Chief Financial Officer · since 2017
Deborah Siu Bik Woo
President of Asia · since 2016
Brent L. Neidig
Executive Vice President - China · since 2017
Daniel A. Macuga
Chief Communications and Marketing Officer · since 2017
Robert A. Sinnott
Chief Scientific Officer · since 2016
Paul A. Jones
Chief Leadership Development Officer · since 2017
David Mulham
Chief Field Development Officer · since 2017
James H. Bramble
Chief Legal Officer and Corporate Secretary · since 2011
J. Scott Nixon
Independent Director · since 2017
Feng Peng
Independent Director · since 2016
Frederic J. Winssinger
Independent Director · since 2016
Legal address
C/O CORPORATION SERVICE COMPANY
15 WEST SOUTH TEMPLE, SUITE 600
Salt Lake City, UT 84101
US
15 WEST SOUTH TEMPLE, SUITE 600
Salt Lake City, UT 84101
US
Headquarters
3838 West Parkway Boulevard
Salt Lake City, UT 84120
US
Salt Lake City, UT 84120
US
Previous name
USANA, INC.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑00 | 2024‑12 | 2023‑12 | 2023‑12 | 2022‑12 | 2022‑00 | 2021‑12 | 2021‑00 | 2020‑12 | 2019‑12 | 2019‑12 | 2018‑12 | 2018‑12 | 2017‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||||||
Revenues | ||||||||||||||||
Cost of revenue | ||||||||||||||||
Unusual Expense (Income) | ||||||||||||||||
NOPBT | ||||||||||||||||
NOPBT Margin | ||||||||||||||||
Operating Taxes | ||||||||||||||||
Tax Rate | ||||||||||||||||
NOPAT | ||||||||||||||||
Net income | ||||||||||||||||
Dividends | ||||||||||||||||
Dividend yield | ||||||||||||||||
Proceeds from repurchase of equity | ||||||||||||||||
BB yield | ||||||||||||||||
| Debt | ||||||||||||||||
Debt current | ||||||||||||||||
Long-term debt | ||||||||||||||||
Deferred revenue | ||||||||||||||||
Other long-term liabilities | ||||||||||||||||
Net debt | ||||||||||||||||
| Cash flow | ||||||||||||||||
Cash from operating activities | ||||||||||||||||
CAPEX | ||||||||||||||||
Cash from investing activities | ||||||||||||||||
Cash from financing activities | ||||||||||||||||
FCF | ||||||||||||||||
| Balance | ||||||||||||||||
Cash | ||||||||||||||||
Long term investments | ||||||||||||||||
Excess cash | ||||||||||||||||
Stockholders' equity | ||||||||||||||||
Invested Capital | ||||||||||||||||
ROIC | ||||||||||||||||
ROCE | ||||||||||||||||
| EV | ||||||||||||||||
Common stock shares outstanding | ||||||||||||||||
Price | ||||||||||||||||
Market cap | ||||||||||||||||
EV | ||||||||||||||||
EBITDA | ||||||||||||||||
EV/EBITDA | ||||||||||||||||
Interest | ||||||||||||||||
Interest/NOPBT | ||||||||||||||||